Intelligent Bio Solutions Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Intelligent Bio Solutions Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- INBS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001725430
Board of directors
-
Christopher Towers ยท DirectorSince 2023
-
Jason Isenberg ยท DirectorSince 2026
-
Jonathan Scott Hurd ยท DirectorSince 2026
-
Nicola Marion Fraser ยท DirectorSince 2024
-
Steven Constantine Boyages ยท DirectorSince 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Steven Constantine Boyages Director | Grant or award | +5,000 | โ | โ |
| Mar 18, 2026 | Nicola Marion Fraser Director | Grant or award | +5,000 | โ | โ |
| Mar 18, 2026 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Grant or award | +9,150 | โ | โ |
| Mar 18, 2026 | Jonathan Scott Hurd Director | Grant or award | +5,000 | โ | โ |
| Mar 18, 2026 | Jason Isenberg Director | Grant or award | +5,000 | โ | โ |
| Mar 18, 2026 | Simeonidis Harry Officer (Chief Executive Officer) | Grant or award | +9,150 | โ | โ |
| Mar 18, 2026 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Grant or award | +21,350 | โ | โ |
| Mar 18, 2026 | Simeonidis Harry Officer (Chief Executive Officer) | Grant or award | +21,350 | โ | โ |
| Sep 25, 2024 | Simeonidis Harry Officer (Chief Executive Officer) | Grant or award | +40,000 | โ | โ |
| Sep 25, 2024 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Grant or award | +34,500 | โ | โ |
| Mar 20, 2024 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | In-the-money exercise | +9,394 | โ | โ |
| Oct 4, 2023 | Christopher Towers Director | Open-market purchase | +9,090 | โ | โ |
| Oct 4, 2023 | Sakiris Spiro Kevin Officer (Chief Financial Officer) | Open-market purchase | +112,727 | โ | โ |
| Sep 1, 2023 | Simeonidis Harry Officer (CEO) | Open-market purchase | +50 | $1.85 | $93 |
| Aug 31, 2023 | Simeonidis Harry Officer (CEO) | Open-market purchase | +100 | $1.92 | $192 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.